An alignment-independent 3D-QSAR study on series of hydroxamic acid-based tumor necrosis factor-α converting enzyme inhibitors
An alignment-independent 3D-QSAR study on series of hydroxamic acid-based tumor necrosis factor-α converting enzyme inhibitors
نویسندگان: سیاوش دستمالچی , مریم حمزه میوه رود , علی اکبر علیزاده , بابک سکوتی
کلمات کلیدی: 3D‐QSAR, docking, GRIND descriptors, TACE inhibitors, TNF‐α
نشریه: , 9 , 30 , 2016
| نویسنده ثبت کننده مقاله |
سیاوش دستمالچی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات بیوتکنولوژی(زیست فناوری) |
| کد مقاله |
61734 |
| عنوان فارسی مقاله |
An alignment-independent 3D-QSAR study on series of hydroxamic acid-based tumor necrosis factor-α converting enzyme inhibitors |
| عنوان لاتین مقاله |
An alignment-independent 3D-QSAR study on series of hydroxamic acid-based tumor necrosis factor-α converting enzyme inhibitors |
| ناشر |
4 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
Journal of Chemometrics |
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
http://onlinelibrary.wiley.com/doi/10.1002/cem.2817/abstract |
| Grid-independent descriptors are extensively used in 3D quantitative structure-activity relationship (3D-QSAR) studies. These kinds of descriptors represent the spatial arrangement of the atoms in a 3D fashion. In the current study, we have developed a 3D-QSAR model for a set of hydroxamic acid-based derivatives as tumor necrosis factor-α converting enzyme (TACE) inhibitors. The generated model revealed the importance of some main moieties in the potency of these compounds. Quinolinyl and hydroxamate moieties have the ability to act as hydrogen bond acceptors and hot spot points. On the other hand, phenyl ring can participate in hydrophobic contacts with the receptor. 3D-QSAR analyses resulted in the partial least squares model of 3 latent variables with internal and external validation yielding q2 values of 0.66 and 0.73, respectively. The result of the current study can be used in designing of potent TACE inhibitors where inhibition of TACE enzyme is required, such as inflammatory diseases, atherosclerosis, osteoporosis, autoimmune disorders, allograft rejection, and cancer. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| alizadeh2016.pdf | 1396/08/16 | 3346261 | دانلود |